18 - 21 November 2019, Düsseldorf, Germany.
Advanced therapies are a major part of new Innovative Medicines Initiative (IMI) Calls for proposals. The two advanced therapies topics aim to accelerate research into advanced therapies for rare diseases, and support the development of engineered T cells to fight cancer. Other topics in the Calls address artificial intelligence; the need for reliable, relevant health information; and ways of incorporating patients' views and experiences into healthcare and cancer clinical trials.
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded project PRIMAGE, which exploits precision information from medical imaging to establish tumor prognosis, and expected treatment response using radiomics, imaging biomarkers and artificial intelligence (AI).
Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping into the power of emerging data technologies. The collaboration aims to change how Sanofi develops new treatments and will focus on three key objectives:
GPs and other prescribers have been prompted more than 5 million times in the last 12 months to encourage patients to take action to look after themselves, rather than relying on medication from their doctor.
A national analysis of how practices in two thirds of England’s CCGs use a prescribing decision support technology called OptimiseRx found that thousands of professionals had been acting on the alerts, helping prescribers to comply with self-care prescribing guidelines from NHS England.
| Location: | Dublin, Ireland |
| Job Type: | Full-Time |
| Employer: | Roche |